doi: 10.1111/jne.12257 108 TelesMGBiancoSDBritoVNTrarbachEBKuohungWXuSet al
It is important for fighting off viral infections through the activation of macrophages, natural killer cells, and T cells
Common adverse effects include nausea, vomiting, diarrhea, constipation, and abdominal pain, which typically diminish over time as the body adjusts to treatment
Effects of tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist, on biomarkers of nonalcoholic steatohepatitis (NASH) in patients with T2D
By reducing cravings and slowing digestion, tirzepatide makes it easier to maintain a calorie deficit and achieve sustainable weight loss
Documentation shows patients have administered 5-20 times their prescribed dose